争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 9 条
2021
赛诺菲员工因计划裁员举行罢工
公众反弹
2021年1月,赛诺菲工会在法国一处研发设施举行了一天罢工,抗议计划中的裁员。工会成员称,裁员可能拖慢抗击新冠疫情的进程。据报道,此次行动是这家法国新冠疫苗制造商因裁员问题举行的罢工。
来源摘录
They said that hundreds of planned job cuts in France could slow the fight against the coronavirus pandemic.
Unions at French drug maker Sanofi have held a one-day strike at the lab where it is developing a Covid-19 vaccine to protest against job cuts.
2021
弗吉尼亚州女性就 Zantac 提起癌症诉讼
提起诉讼
在2021年8月报道的一起诉讼中,Deborah Haskins 起诉 Zantac 的制造商,指称该药导致其食管癌,且制造商未向消费者警示风险。报道称,研究尚未明确证明 Zantac 与癌症有关。该报道仅涉及起诉及原告的指控,未提及法院裁决、和解或监管结论。
来源摘录
In the lawsuit, Haskins also noted that if she had known about the unsafe levels of NDMA in Zantac, she never would have purchased the medication.
The lawsuit named Sanofi, Zantac's current manufacturer in the U.S. as a defendant. It also included previous makers, Boehringer Ingelheim Pharmaceuticals and GlaxoSmithKline.
While research has not explicitly linked Zantac to cancer, the esophagus is acted upon by the drug.
2020
赛诺菲澄清其对全球疫苗获取的立场
公司回应
赛诺菲澄清,该公司研发的任何新冠疫苗都将向所有人提供。此前,其首席执行官关于美国生产剂量可能优先提供给美国患者的言论引发法国政府不满。该首席执行官表示,他对先前言论引发风波感到抱歉。
在执行长先前关于美国生产的疫苗剂量可能优先提供给美国患者的言论引发法国政府不满后,赛诺菲澄清,该公司研发的任何新冠疫苗都将向所有人提供。执行长表示,他对先前言论引发风波感到抱歉。
品牌回应
澄清 — Sanofi
Sanofi, which has urged stronger European coordination in the hunt for a vaccine and has US. financial support, clarified that any such vaccine would be made available to all.
道歉 — Sanofi
he was sorry that his earlier remarks had created such a storm
来源摘录
Hudson said yesterday it was vital that any coronavirus vaccine reach all regions and he was sorry that his earlier remarks had created such a storm.
PARIS, May 15 — Sanofi chief executive Paul Hudson said yesterday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying some countries would get priority access.
Sanofi, which has urged stronger European coordination in the hunt for a vaccine and has US. financial support, clarified that any such vaccine would be made available to all.
2020
赛诺菲停止 Kevzara 新冠临床试验
整改
在试验发现部分患者出现包括肺炎和死亡在内的不良反应后,赛诺菲停止了 Kevzara 用于新冠治疗的临床试验。该公司表示不再计划开展该药物的进一步新冠临床研究。
来源摘录
Sanofi has stopped the clinical trials of Kevzara, one of the drugs being tested to treat COVID-19.
On Tuesday, Sanofi said it had no longer plans to conduct further clinical studies for Kevzara in COVID-19
It manufactures Kevzara in partnership with American firm Regeneron.
2020
法院在 Sanofi 诉讼中作出有利于 Mylan 的简易判决
裁决
美国堪萨斯州联邦地区法院在 Sanofi 因 EpiPen 产品提起的诉讼中作出有利于 Mylan 的简易判决。Viatris 称法院此举驳回了 Sanofi 关于反竞争行为的主张。来源报道的是有利于 Mylan 的判决,并未另行认定存在不当行为。
当事方说明的目的. 追回该县称已向这些公司支付的超过 2700 万美元。
来源摘录
Viatris Inc. (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas entered summary judgment in Mylan's favor in the lawsuit brought against it by Sanofi related to its EpiPen® products.
it rejects Sanofi's baseless attempts to argue that Mylan used anticompetitive practices to market EpiPen
Harris County is suing three insulin manufacturers and four pharmaceutical benefit managers, claiming they colluded to drive up the price of insulin.
2020
赛诺菲美国公司与联邦政府达成 1,185 万美元和解协议
和解
赛诺菲美国公司宣布与联邦政府达成 1,185 万美元和解协议,以解决一项涉及其在 2015 年和 2016 年向独立慈善患者援助基金会捐款的调查。公司表示,该和解不构成承认有罪。
当事方说明的目的. 解决一项涉及 2015 年和 2016 年特定财务捐款的调查。
来源摘录
Sanofi U.S. today announced that it has reached an $11.85 million settlement agreement with the federal government to resolve an investigation relating to certain financial donations made in 2015 and 2016 to an independent charity patient assistance foundation that aided patients living with multiple sclerosis.
It does not constitute any admission of guilt.
2019
赛诺菲在美国和加拿大召回 Zantac
宣布召回
2019年10月,赛诺菲宣布将在美国和加拿大自愿召回 Zantac。据该公司表示,此次召回将在赛诺菲与监管机构调查该药物中检测到的 NDMA 期间进行。该公告涉及在调查期间从两国市场撤回该产品。
品牌回应
召回 — Sanofi
Sanofi said Friday it will recall the widely-used heartburn drug Zantac from stores in the United States and Canada
来源摘录
Sanofi said Friday it will recall the widely-used heartburn drug Zantac from stores in the United States and Canada as the drugmaker and Food and Drug Administration investigate a probable carcinogen detected in the drug.
The FDA last month said it discovered a probable carcinogen called NDMA, or nitrosodimethylamine, in the drug Zantac and its generic versions.
2019
赛诺菲台湾同意回收 Tritace U322 批次
宣布召回
部分 Tritace 10mg U322 批次锭剂发现黑点、疑似遭污染后,赛诺菲台湾同意预防性回收整批产品。食药署表示,赛诺菲台湾须于 1 月 9 日前完成回收。
品牌回应
召回 — Sanofi Taiwan Co
the company said it was willing to issue a preventive recall of the whole batch.
来源摘录
Pharmaceutical firm Sanofi Taiwan Co has agreed to recall a batch of heart disease medicine due to possible contamination, the Food and Drug Administration (FDA) said yesterday.
The FDA said in a statement that it had received a report about suspected contamination in Tritace 10mg tablets with the batch number U322, as dark spots were found on some tablets.
Taiwan’s Food and Drug Administration on Monday announced a recall of the tablets.
2006